EYES Annual FCF
-$9.20 M
+$7.95 M+46.35%
31 December 2021
Summary:
As of January 21, 2025, EYES annual free cash flow is -$9.20 million, with the most recent change of +$7.95 million (+46.35%) on December 31, 2021. During the last 3 years, it has risen by +$20.77 million (+69.30%).EYES Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Quarterly FCF
-$3.22 M
-$1.23 M-61.67%
30 June 2022
Summary:
As of January 21, 2025, EYES quarterly free cash flow is -$3.22 million, with the most recent change of -$1.23 million (-61.67%) on June 30, 2022. Over the past year, it has increased by +$963.00 thousand (+23.01%).EYES Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES TTM FCF
-$9.44 M
+$963.00 K+9.26%
30 June 2022
Summary:
As of January 21, 2025, EYES TTM free cash flow is -$9.44 million, with the most recent change of +$963.00 thousand (+9.26%) on June 30, 2022. Over the past year, it has dropped by -$1.55 million (-19.60%).EYES TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.4% | +23.0% | -19.6% |
| 3 y3 years | +69.3% | +52.4% | +66.4% |
| 5 y5 years | +62.0% | +46.5% | +66.4% |
EYES Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | +314.1% | +101.6% |
Second Sight Medical Products Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$3.22 M(+61.7%) | -$9.44 M(-9.3%) |
| Mar 2022 | - | -$1.99 M(-17.8%) | -$10.40 M(+13.2%) |
| Dec 2021 | -$9.20 M(-46.4%) | -$2.42 M(+34.7%) | -$9.19 M(+11.8%) |
| Sept 2021 | - | -$1.80 M(-57.0%) | -$8.21 M(+4.1%) |
| June 2021 | - | -$4.18 M(+437.9%) | -$7.89 M(-11.8%) |
| Mar 2021 | - | -$778.00 K(-46.4%) | -$8.95 M(-47.8%) |
| Dec 2020 | -$17.15 M(-39.0%) | -$1.45 M(-1.8%) | -$17.15 M(-26.0%) |
| Sept 2020 | - | -$1.48 M(-71.8%) | -$23.18 M(-18.3%) |
| June 2020 | - | -$5.24 M(-41.7%) | -$28.39 M(-5.1%) |
| Mar 2020 | - | -$8.98 M(+20.0%) | -$29.92 M(+6.4%) |
| Dec 2019 | -$28.12 M(-6.2%) | -$7.49 M(+11.9%) | -$28.12 M(-0.9%) |
| Sept 2019 | - | -$6.69 M(-1.1%) | -$28.39 M(-2.7%) |
| June 2019 | - | -$6.76 M(-5.9%) | -$29.18 M(-3.7%) |
| Mar 2019 | - | -$7.19 M(-7.3%) | -$30.31 M(+1.1%) |
| Dec 2018 | -$29.97 M(+23.8%) | -$7.75 M(+3.6%) | -$29.97 M(+3.3%) |
| Sept 2018 | - | -$7.48 M(-5.2%) | -$29.02 M(+10.6%) |
| June 2018 | - | -$7.89 M(+15.3%) | -$26.25 M(+7.7%) |
| Mar 2018 | - | -$6.85 M(+0.7%) | -$24.37 M(+0.7%) |
| Dec 2017 | -$24.21 M | -$6.80 M(+44.4%) | -$24.21 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$4.71 M(-21.8%) | -$24.51 M(-5.2%) |
| June 2017 | - | -$6.02 M(-10.0%) | -$25.86 M(-1.0%) |
| Mar 2017 | - | -$6.69 M(-5.8%) | -$26.11 M(+2.2%) |
| Dec 2016 | -$25.56 M(+19.9%) | -$7.10 M(+17.2%) | -$25.56 M(+4.2%) |
| Sept 2016 | - | -$6.06 M(-3.3%) | -$24.54 M(+4.3%) |
| June 2016 | - | -$6.27 M(+2.2%) | -$23.53 M(+5.3%) |
| Mar 2016 | - | -$6.13 M(+0.9%) | -$22.34 M(+4.8%) |
| Dec 2015 | -$21.31 M(+20.7%) | -$6.08 M(+20.5%) | -$21.31 M(+29.6%) |
| Sept 2015 | - | -$5.04 M(-0.6%) | -$16.44 M(-4.8%) |
| June 2015 | - | -$5.08 M(-0.6%) | -$17.28 M(-4.1%) |
| Mar 2015 | - | -$5.11 M(+321.3%) | -$18.01 M(+2.0%) |
| Dec 2014 | -$17.65 M(-0.1%) | -$1.21 M(-79.4%) | -$17.65 M(-17.9%) |
| Sept 2014 | - | -$5.88 M(+1.2%) | -$21.51 M(+10.6%) |
| June 2014 | - | -$5.81 M(+22.4%) | -$19.45 M(+9.7%) |
| Mar 2014 | - | -$4.75 M(-6.4%) | -$17.74 M(+0.4%) |
| Dec 2013 | -$17.67 M(+13.9%) | -$5.07 M(+32.8%) | -$17.67 M(+40.3%) |
| Sept 2013 | - | -$3.82 M(-6.8%) | -$12.60 M(+43.5%) |
| June 2013 | - | -$4.10 M(-12.5%) | -$8.78 M(+87.5%) |
| Mar 2013 | - | -$4.68 M | -$4.68 M |
| Dec 2012 | -$15.52 M | - | - |
FAQ
- What is Second Sight Medical Products annual free cash flow?
- What is the all time high annual FCF for Second Sight Medical Products?
- What is Second Sight Medical Products annual FCF year-on-year change?
- What is Second Sight Medical Products quarterly free cash flow?
- What is the all time high quarterly FCF for Second Sight Medical Products?
- What is Second Sight Medical Products quarterly FCF year-on-year change?
- What is Second Sight Medical Products TTM free cash flow?
- What is the all time high TTM FCF for Second Sight Medical Products?
- What is Second Sight Medical Products TTM FCF year-on-year change?
What is Second Sight Medical Products annual free cash flow?
The current annual FCF of EYES is -$9.20 M
What is the all time high annual FCF for Second Sight Medical Products?
Second Sight Medical Products all-time high annual free cash flow is -$9.20 M
What is Second Sight Medical Products annual FCF year-on-year change?
Over the past year, EYES annual free cash flow has changed by +$7.95 M (+46.35%)
What is Second Sight Medical Products quarterly free cash flow?
The current quarterly FCF of EYES is -$3.22 M
What is the all time high quarterly FCF for Second Sight Medical Products?
Second Sight Medical Products all-time high quarterly free cash flow is -$778.00 K
What is Second Sight Medical Products quarterly FCF year-on-year change?
Over the past year, EYES quarterly free cash flow has changed by +$963.00 K (+23.01%)
What is Second Sight Medical Products TTM free cash flow?
The current TTM FCF of EYES is -$9.44 M
What is the all time high TTM FCF for Second Sight Medical Products?
Second Sight Medical Products all-time high TTM free cash flow is -$4.68 M
What is Second Sight Medical Products TTM FCF year-on-year change?
Over the past year, EYES TTM free cash flow has changed by -$1.55 M (-19.60%)